Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with End-Stage Renal Disease on Hemodialysis: A Narrative Review

被引:4
|
作者
Egashira, Shuhei [1 ]
Koga, Masatoshi [1 ]
Toyoda, Kazunori [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovascular Med, 6-1 Kishibe Shimmachi,Suita, Osaka 5648565, Japan
关键词
intravenous thrombolysis; acute ischemic stroke; end-stage renal disease; hemodialysis; activated partial thromboplastin time; TISSUE-PLASMINOGEN-ACTIVATOR; RISK-FACTOR ASSESSMENT; MAINTENANCE HEMODIALYSIS; ATRIAL-FIBRILLATION; ENDOVASCULAR TREATMENT; ACUTE MANAGEMENT; RT-PA; DIALYSIS; OUTCOMES; MORTALITY;
D O I
10.3390/jcdd9120446
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Acute ischemic stroke (AIS) is a significant and devastating complication in patients with end-stage renal disease on hemodialysis (ESRD/HD). Since one-third of AIS in ESRD/HD patients occurs during or soon after dialysis, patients are more likely to present within the time window when intravenous thrombolysis (IVT) can be performed. IVT may improve prognosis in ESRD/HD patients with AIS. However, ESRD/HD patients have been excluded from large trials and may have been withheld from IVT due to concerns about bleeding complications. To date, there is no clear evidence and firm guidance on the safety and efficacy of IVT in ESRD/HD patients with AIS. This narrative review aimed to evaluate critical scientific data on the benefits and risks of IVT use in patients with ESRD/HD and AIS. Materials and Methods: We searched the electronic database of PubMed for studies evaluating the relationship between AIS, ESRD/HD, and IVT. Reference sections and additional publications were also searched manually. Studies on AIS in patients with ESRD/HD requiring maintenance dialysis that referred to IVT were included. Results: In total, 560 studies were found in the PubMed electronic database during the period covered, of which 10 met the selection criteria. IVT for AIS in ESRD/HD patients could improve neurological outcomes and be safely performed even with the possibility of hemorrhagic complications associated with hypertension. Despite the high complication and mortality rates in ESRD/HD patients with AIS after IVT, the association with IVT was unclear. Conclusions: IVT for AIS in ESRD/HD patients may improve outcomes and should not be withheld based solely on ESRD/HD status.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] THE PHARMACOKINETICS OF AMINOGUANIDINE IN END-STAGE RENAL-DISEASE PATIENTS ON HEMODIALYSIS
    FOOTE, EF
    LOOK, ZM
    GILES, P
    KEANE, WF
    HALSTENSON, CE
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) : 420 - 425
  • [42] Dental Care for Patients with End-Stage Renal Disease and Undergoing Hemodialysis
    Costantinides, Fulvia
    Castronovo, Gaetano
    Vettori, Erica
    Frattini, Costanza
    Artero, Mary Louise
    Bevilacqua, Lorenzo
    Berton, Federico
    Nicolin, Vanessa
    Di Lenarda, Roberto
    INTERNATIONAL JOURNAL OF DENTISTRY, 2018, 2018
  • [43] FGF-23 in patients with end-stage renal disease on hemodialysis
    Imanishi, Y
    Nakatsuka, K
    Inaba, M
    Nagasue, K
    Okuno, S
    Miura, M
    Miyauchi, A
    Kobayashi, K
    Ishimura, E
    Nishizawa, Y
    BONE, 2003, 32 (05) : S116 - S116
  • [44] PHARMACOKINETICS AND PHARMACODYNAMICS OF EVOGLIPTIN IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS
    Kim, B.
    Yu, K.
    Lee, S.
    Oh, J.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S67 - S67
  • [45] Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis
    Teigen, Mette Maja B.
    Duffull, Stephen
    Dang, Lily
    Johnson, David W.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11): : 1259 - 1267
  • [46] Survival of patients with AIDS and end-stage renal disease receiving hemodialysis
    Ifudu, O
    Salifu, MO
    Reydel, C
    DiRienzo, R
    McClendon, E
    Bley, A
    Waltrous, C
    Oguagha, C
    Friedman, EA
    DIALYSIS & TRANSPLANTATION, 2004, 33 (04) : 176 - +
  • [47] Ocular changes during hemodialysis in patients with end-stage renal disease
    Chen, Hejun
    Zhang, Xi
    Shen, Xi
    BMC OPHTHALMOLOGY, 2018, 18
  • [48] Effects of hemodialysis on arterial function in end-stage renal disease patients
    Sun, N. L.
    Xi, Y.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S49 - S49
  • [49] FGF-23 in patients with end-stage renal disease on hemodialysis
    Imanishi, Y
    Inaba, M
    Nakatsuka, K
    Nagasue, K
    Okuno, S
    Yoshihara, A
    Miura, M
    Miyauchi, A
    Kobayashi, K
    Miki, T
    Shoji, T
    Ishimura, E
    Nishizawa, Y
    KIDNEY INTERNATIONAL, 2004, 65 (05) : 1943 - 1946
  • [50] Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis in a Developing Country
    Silva, Leila S. V.
    Oliveira, Rodrigo A.
    Silva Junior, Geraldo B.
    Lima, Jose Wellington O.
    Silva, Ricardo P.
    Liborio, Alexandre B.
    Daher, Elizabeth F.
    Sobrinho, Carlos Roberto R. M.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2012, 23 (02) : 262 - 266